Pulmonology Top News: Spiriva Signal, LABA Risk

(MedPage Today) -- A heart attack signal with tiotropium (Spiriva) and a potential genetic explanation for severe adverse events with long-acting beta agonists (LABAs) in asthma topped the news in pulmonology this week.
Source: MedPage Today Allergy - Category: Allergy & Immunology Source Type: news